Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Equal-Weight on DexCom, Lowers Price Target to $492

Morgan Stanley analyst David Lewis maintains DexCom (NASDAQ:DXCM) with a Equal-Weight and lowers the price target from $514 to $492.
byBenzinga Newsdesk
April 29, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Morgan Stanley analyst David Lewis maintains DexCom (NASDAQ:DXCM) with a Equal-Weight and lowers the price target from $514 to $492.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0